GHSI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GHSI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Guardion Health Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $7.345. Guardion Health Sciences's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.
As of today (2024-12-12), Guardion Health Sciences's share price is $3.22. Guardion Health Sciences's Median PS Value is $0.00. Therefore, Guardion Health Sciences's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Guardion Health Sciences's Median PS Value or its related term are showing as below:
The historical data trend for Guardion Health Sciences's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardion Health Sciences Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
Median PS Value | Get a 7-Day Free Trial | - | - | - | - | - |
Guardion Health Sciences Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Median PS Value | Get a 7-Day Free Trial | - | - | - | - | - |
For the Drug Manufacturers - Specialty & Generic subindustry, Guardion Health Sciences's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Guardion Health Sciences's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Guardion Health Sciences's Price-to-Median-PS-Value falls into.
Guardion Health Sciences's Median PS Value for today is calculated as
Median PS Value | = | Revenue per Share (TTM) | * | 10-Year Median PS Ratio |
= | 7.345 | * | 0 | |
= | 0.00 |
10-Year Median PS Ratio is 0.
Guardion Health Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.345.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardion Health Sciences (OTCPK:GHSI) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Guardion Health Sciences's Price to Median PS Value for today is calculated as
Price to Median PS Value | = | Share Price | / | Median PS Value |
= | 3.22 | / | 0.00 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Guardion Health Sciences's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Bradley Louis Radoff | 10 percent owner | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
Katharine Joan Cox | officer: Chief Accounting Officer | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Janet Hall | officer: CEO & President | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Family Foundation Radoff | other: See Footnote 1 | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
Michaela Griggs | director | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Bret Scholtes | director, officer: Chief Executive Officer | 2105 CITY WEST BLVD., SUITE 500, HOUSTON TX 77042 |
Donald A Gagliano | director | 131 CARDINAL AVE, SAN ANTONIO TX 78209 |
Jeffrey S Benjamin | officer: Chief Accounting Officer | 3885 CRESTWOOD PARKWAY, SUITE 550, DULUTH GA 30096 |
Craig Sheehan | officer: Chief Commercial Officer | 15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128 |
Andrew C Schmidt | officer: Chief Financial Officer | 1700 CARNEGIE AVE, SUITE 100, SANTA ANA CA 92705 |
Kelly Anderson | director | C/O TOMI ENVIRONMENTAL SOLUTIONS, INC., 9454 WILSHIRE BLVD., R-1, BEVERLY HILLS CA 90212 |
David W Evans | director, officer: Chief Scientific Officer | 4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117 |
Tamara A Evans | 10 percent owner | 4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117 |
John Townsend | other: Controller | 15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128 |
Gordon Bethwaite | officer: Vice Pres, Sales and Marketing | 15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128 |
From GuruFocus
By GuruFocus Research • 02-07-2024
By GlobeNewswire GlobeNewswire • 11-29-2022
By sperokesalga sperokesalga • 05-30-2023
By Marketwired • 10-01-2024
By Marketwired • 08-21-2024
By GuruFocusNews GuruFocusNews • 07-05-2022
By GuruFocusNews GuruFocusNews • 07-09-2022
By Marketwired • 08-14-2023
By Stock market mentor Stock market mentor • 01-06-2023
By Value_Insider Value_Insider • 11-14-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.